EGFR and neoplasm: It was found that FKC treatment suppressed tumor volume and weight and inhibited glycolysis and angiogenesis-related protein expression and phosphorylation of the EGFR/PI3K/Akt/mTOR pathway, whereas knockdown of HSP90B1 strengthened the effect of FKC.